The Danish Embassy in Washington, DC is pleased to announce an exciting series of virtual seminars led by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) - addressing regulatory developments and trends in the USA and Europe. In the 4-part series of focused sessions, FDA and EMA officials will present how they work together and where they are different in addressing innovation, advancements and approval of new medical products.
Each session will focus on a specific theme addressing related topics and incorporate recent examples and relevant cases.
Sessions will be interactive with a Q&A period following each presentation. Session titles are shown below with detailed descriptions available via the link further below.
March 22: Transatlantic Cooperation in Medical Products Regulation
April 19: What’s new in Oncology
May 17: Patients in Drug Development & Regulatory Processes
June 4: Innovations in Therapy & Digital Transformations
Why attend?
- Hear the latest developments in regulatory science directly from FDA & EMA
- Follow current trends in adapting regulations in the development and innovation of drugs and medical technologies
- Understand critical changes underway to create successful strategies in the USA & Europe
- Benchmark your regulatory strategies against agency requirements
- Reserve a brief private one on one meeting with FDA & EMA officials
Who should attend?
Professionals in Research & Development, Regulatory Affairs, Medical Affairs, Corporate Strategy & Business Development, Market Access & Policy, Health Technology and Patient Advocacy